Publikationen, an denen er mitarbeitet MIGUEL ANGEL SERRA DESFILIS (32)

2024

  1. Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score

    Liver International, Vol. 44, Núm. 1, pp. 202-213

2022

  1. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease

    Radiology, Vol. 302, Núm. 2, pp. 345-354

  2. Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Digital pathology enables automated and quantitative assessment of inflammatory activity in patients with chronic liver disease

    Biomolecules, Vol. 11, Núm. 12

  2. Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease

    Alimentary Pharmacology and Therapeutics, Vol. 53, Núm. 1, pp. 160-171

2018

  1. Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment

    Free Radical Research, Vol. 52, Núm. 1, pp. 118-133

  2. Learning and Memory Impairments in Patients with Minimal Hepatic Encephalopathy are Associated with Structural and Functional Connectivity Alterations in Hippocampus

    Scientific Reports, Vol. 8, Núm. 1

  3. Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression

    Journal of Gastroenterology and Hepatology (Australia), Vol. 33, Núm. 3, pp. 718-725

2017

  1. Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits

    Liver International, Vol. 37, Núm. 7, pp. 1013-1022

  2. Minimal hepatic encephalopathy is associated with expansion and activation of CD4+CD28-, Th22 and Tfh and B lymphocytes

    Scientific Reports, Vol. 7, Núm. 1

  3. Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy

    PLoS ONE, Vol. 12, Núm. 10

  4. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients

    PLoS ONE, Vol. 12, Núm. 2

2015

  1. Is Cognitive Impairment in Cirrhotic Patients Due to Increased Peroxynitrite and Oxidative Stress?

    Antioxidants and Redox Signaling, Vol. 22, Núm. 10, pp. 871-877

  2. Minimal Hepatic Encephalopathy and Critical Flicker Frequency Are Associated with Survival of Patients with Cirrhosis

    Gastroenterology, Vol. 149, Núm. 6, pp. 1483-1489

2014

  1. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests

    World Journal of Gastroenterology, Vol. 20, Núm. 33, pp. 11815-11825

  2. Reduced white matter microstructural integrity correlates with cognitive deficits in minimal hepatic encephalopathy

    Gut

2013

  1. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy

    Liver International, Vol. 33, Núm. 10, pp. 1478-1489

2012

  1. Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy

    Metabolic Brain Disease, Vol. 27, Núm. 1, pp. 51-58

  2. Focal cortical damage parallels cognitive impairment in minimal hepatic encephalopathy

    NeuroImage, Vol. 61, Núm. 4, pp. 1165-1175

  3. Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests

    Hepatology, Vol. 55, Núm. 2, pp. 530-539